Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick L Altice

Showing results (91-100 of 475) with videos related to

Pageof 48
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2008
Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populationsDuncan Smith-Rohrberg Maru, Robert Douglas Bruce, Sanjay Basu, et al.
The International Journal on Drug Policy|September 19, 2016
The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven samplingAlexei Zelenev, Elisa Long, Alexander R Bazazi, et al.
Plos One|March 26, 2013
Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the communityLyuba Azbel, Jeffrey A Wickersham, Yevgeny Grishaev, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 22, 2014
Emergency department use among HIV-infected released jail detaineesAndrew T Boyd, Dahye L Song, Jaimie P Meyer, et al.
Journal of the International AIDS Society|September 13, 2014
Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisonersLyuba Azbel, Jeffrey A Wickersham, Yevgeny Grishaev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Public health implications for adequate transitional care for HIV-infected prisoners: five essential componentsSandra A Springer, Anne C Spaulding, Jaimie P Meyer, et al.
Contemporary Clinical Trials|June 24, 2019
Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB studyRoman Shrestha, Frederick L Altice, Brian Sibilio, et al.
Plos One|June 22, 2012
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersSandra A Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani, et al.
The American Journal of Drug and Alcohol Abuse|February 13, 2009
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian marketR Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Plos One|February 7, 2015
Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United StatesDahye L Song, Frederick L Altice, Michael M Copenhaver, et al.
Pageof 48

Showing results (91-100 of 475) with videos related to

Sort By:
Pageof 48
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2008
Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populationsDuncan Smith-Rohrberg Maru, Robert Douglas Bruce, Sanjay Basu, et al.
The International Journal on Drug Policy|September 19, 2016
The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven samplingAlexei Zelenev, Elisa Long, Alexander R Bazazi, et al.
Plos One|March 26, 2013
Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the communityLyuba Azbel, Jeffrey A Wickersham, Yevgeny Grishaev, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 22, 2014
Emergency department use among HIV-infected released jail detaineesAndrew T Boyd, Dahye L Song, Jaimie P Meyer, et al.
Journal of the International AIDS Society|September 13, 2014
Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisonersLyuba Azbel, Jeffrey A Wickersham, Yevgeny Grishaev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 17, 2011
Public health implications for adequate transitional care for HIV-infected prisoners: five essential componentsSandra A Springer, Anne C Spaulding, Jaimie P Meyer, et al.
Contemporary Clinical Trials|June 24, 2019
Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB studyRoman Shrestha, Frederick L Altice, Brian Sibilio, et al.
Plos One|June 22, 2012
Retention on buprenorphine is associated with high levels of maximal viral suppression among HIV-infected opioid dependent released prisonersSandra A Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani, et al.
The American Journal of Drug and Alcohol Abuse|February 13, 2009
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian marketR Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Plos One|February 7, 2015
Cost-effectiveness analysis of brief and expanded evidence-based risk reduction interventions for HIV-infected people who inject drugs in the United StatesDahye L Song, Frederick L Altice, Michael M Copenhaver, et al.
Pageof 48